" class="no-js "lang="en-US"> Peijia Medical - Medtech Alert
Thursday, March 30, 2023
Peijia Medical | Pharmtech Focus

Peijia Medical

About Peijia Medical

Peijia Medical

A Globally Service Provider of Innovative Medical Products and Solutions

Peijia Medical is a globally service provider of innovative medical products and solutions. Focusing on the innovation, R&D and production of high-end medical devices for structural heart and cerebrovascular disease intervention. It covers the entire product pipeline for the aortic valve, mitral valve and tricuspid valve, as well as surgical instruments and accessories, and diseases related to hemorrhage, ischemia and pathways in the field of cerebrovascular intervention. It has built China’s relatively comprehensive product portfolio and solutions set in the field of structural heart disease and cerebrovascular intervention.

Peijia Medical was established in 2012, is headquartered in Suzhou, Jiangsu Province, China, and was listed on the Main Board of the Hong Kong Stock Exchange in May 2020. Stock Code 9996.HK.

Related Story

Peijia Medical TaurusOne® Approved for Commercialization

April 26 2021

A new interventional solution from China for structural heart disease is about to be launched onto the […]